If a variant has more than one submission, it may be counted in more than one significance column. If this is the
case, the total number of variants will be less than the sum of the other cells.
| pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
not provided |
total |
|
64
|
31
|
1113
|
764
|
61
|
1
|
1994
|
Gene and significance breakdown #
Total genes and gene combinations: 9
| Gene or gene combination |
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
not provided |
total |
|
NRXN1
|
61
|
30
|
1105
|
764
|
60
|
1
|
1982
|
|
LOC110121071, LOC129388861, NRXN1
|
1
|
0 |
2
|
0 |
0 |
0 |
3
|
|
FSHR, NRXN1
|
0 |
0 |
2
|
0 |
0 |
0 |
2
|
|
LOC110121071, LOC129388861, MIR8485, NRXN1
|
2
|
0 |
0 |
0 |
0 |
0 |
2
|
|
LOC114827832, NRXN1
|
0 |
0 |
1
|
0 |
1
|
0 |
2
|
|
FBXO11, FOXN2, FSHR, GTF2A1L, KCNK12, LHCGR, MSH2, MSH2-OT1, MSH6, NRXN1, PPP1R21, STON1, STON1-GTF2A1L
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
|
FBXO11, FOXN2, FSHR, GTF2A1L, LHCGR, MSH6, NRXN1, PPP1R21, STON1, STON1-GTF2A1L
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
|
FSHR, LHCGR, NRXN1, STON1-GTF2A1L
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
|
NRXN1, NRXN1-DT
|
0 |
1
|
0 |
0 |
0 |
0 |
1
|
Submitter and significance breakdown #
| Submitter |
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
not provided |
total |
|
Labcorp Genetics (formerly Invitae), Labcorp
|
53
|
21
|
979
|
750
|
43
|
0 |
1846
|
|
Illumina Laboratory Services, Illumina
|
0 |
0 |
134
|
15
|
27
|
0 |
176
|
|
Revvity Omics, Revvity
|
0 |
4
|
13
|
0 |
0 |
0 |
17
|
|
Baylor Genetics
|
0 |
0 |
9
|
0 |
0 |
0 |
9
|
|
Centre for Mendelian Genomics, University Medical Centre Ljubljana
|
0 |
0 |
3
|
1
|
0 |
0 |
4
|
|
OMIM
|
4
|
0 |
0 |
0 |
0 |
0 |
4
|
|
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
|
4
|
0 |
0 |
0 |
0 |
0 |
4
|
|
New York Genome Center
|
0 |
1
|
2
|
0 |
0 |
0 |
3
|
|
Genetics and Molecular Pathology, SA Pathology
|
1
|
0 |
1
|
0 |
0 |
0 |
2
|
|
HudsonAlpha Institute for Biotechnology, HudsonAlpha Institute for Biotechnology
|
0 |
0 |
0 |
2
|
0 |
0 |
2
|
|
MVZ Martinsried, Medicover Genetics
|
0 |
0 |
2
|
0 |
0 |
0 |
2
|
|
Pittsburgh Clinical Genomics Laboratory, University of Pittsburgh Medical Center
|
0 |
0 |
2
|
0 |
0 |
0 |
2
|
|
Breda Genetics srl, Breda Genetics srl
|
0 |
1
|
0 |
0 |
0 |
0 |
1
|
|
Center of Human Genetics, Hôpital Erasme
|
0 |
1
|
0 |
0 |
0 |
0 |
1
|
|
Daryl Scott Lab, Baylor College of Medicine
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
|
Department of Pathology and Laboratory Medicine, Sinai Health System
|
0 |
1
|
0 |
0 |
0 |
0 |
1
|
|
First Genomix Gene Laboratory, Genetic Diagnostics Department
|
0 |
1
|
0 |
0 |
0 |
0 |
1
|
|
Geisinger Autism and Developmental Medicine Institute, Geisinger Health System
|
1
|
0 |
0 |
0 |
0 |
0 |
1
|
|
GenomeConnect, ClinGen
|
0 |
0 |
0 |
0 |
0 |
1
|
1
|
|
Groupe Hospitalier Pitie Salpetriere, Uf Genomique Du Developpement, Assistance Publique Hopitaux de Paris Sorbonne Université
|
0 |
1
|
0 |
0 |
0 |
0 |
1
|
|
Institute of Human Genetics, University of Leipzig Medical Center
|
1
|
0 |
0 |
0 |
0 |
0 |
1
|
|
Mayo Clinic Laboratories, Mayo Clinic
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
|
Mendelics
|
0 |
0 |
0 |
0 |
1
|
0 |
1
|
|
Neuberg Centre For Genomic Medicine, NCGM
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
|
Variantyx, Inc.
|
0 |
1
|
0 |
0 |
0 |
0 |
1
|
The information on this website is not intended for direct
diagnostic use or medical decision-making without review by a
genetics professional. Individuals should not change their
health behavior solely on the basis of information contained on
this website. The submitted information has not been verified.
If you have questions about the information contained on this
website, please see a health care professional.